D. Burcoveanu

Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An updated analysis

BackgroundNeurotrophic tyrosine receptor kinase ( NTRK ) gene fusions are oncogenic drivers in various tumour types. Larotrectinib is a first-in-class, highly selective, central nervous s...

T. Andre ;

D. Hong ;

J. Deeken ;

A. Italiano ;

T. Liu ;

D. Burcoveanu ;

R. Norenberg ;

C. Mussi ;

R. Xu ;

A. Drilon ;

Liang Shen , PhD;

06/25/2023

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

D. Burcoveanu

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products